Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Uri Ladabaum MD, MS

Uri Ladabaum MD, MS

Professor of Medicine; Director, Gastrointestinal Cancer Prevention Program, Stanford University School of Medicine, Stanford, California

Uri Ladabaum, MD, MS, serves as director of the Gastrointestinal Cancer Prevention Program and heads the Clinical Service of the Division of Gastroenterology and Hepatology at Stanford University School of Medicine. Dr. Ladabaum received his medical degree from the University of California, San Francisco, completed his residency and chief residency in internal medicine at Stanford University Hospital, and fellowship in gastroenterology at the University of Michigan, where he also obtained an MS degree in clinical research design and statistical analysis.

Dr. Ladabaum’s clinical efforts include providing consultation and endoscopic services for persons at average risk or high risk for cancer, and caring for patients and families with suspected or established inherited cancer predisposition syndromes.

Dr. Ladabaum’s research focus is colorectal cancer risk management and prevention. His current and recent areas of investigation include risk stratification and personalized screening, cost-effectiveness analyses of multiple questions related to colorectal cancer screening, quality monitoring and assurance in endoscopy, safety of colonoscopy, and identification and management of families with genetic cancer syndromes.


Dr. Ladabaum reports the following:
  • Advisor: Universal Dx, Lean Medical
  • Active Consulting: Freenome, Guardant, Medtronic, Neptune Medical, Kohler Ventures
  • Recent Consulting: Geneoscopy, Meidal EarlySign, ChekCap

Recent Contributions to PracticeUpdate:

  1. Evaluation of Computer-Aided Detection During Colonoscopy